The startup's in-house projects include GM-1020, a small-molecule NMDA receptor channel blocker – the mechanism of action ... based therapy Spravato (esketamine), which has been approved by ...

Within this Research Topic, five papers delve into alternative treatments for depression, investigating the effects and mechanisms of serotonergic psychedelics (like ayahuasca), oral esketamine, the ...

Trusted resource of information on Anxiety & Depression that includes articles, news, videos, animations, quizzes, ...

Spravato (esketamine) has been touted as a potential blockbuster for Janssen, which faces increasing biosimilar competition from its top-selling rheumatoid arthritis drug Remicade. Estimates from ...

Background Escitalopram is licensed for use at doses up to 20 mg but is used clinically at higher doses. There is limited published data at higher doses and none in the treatment of Major ...

Several fleshy fruits are highly affected by cracking, a severe physiological disorder that compromises their quality and causes high economical losses to the producers. Cracking can occur due to ...